Advertisement
Original communication| Volume 114, ISSUE 5, P928-935, November 1993

Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Background. Treatment regimens with hepatic arterial chemotherapy infusion are being investigated in an attempt to improve survival and quality of life for patients with primary and metastatic liver malignancies. The successful delivery of chemotherapeutic drugs through an implantable hepatic arterial infusion device depends on the surgeon's understanding of hepatic arterial anatomy, the proper cannulation technique, and the operative measures necessary to prevent misperfusion of drug.
      Methods. Between January 1, 1987, and December 31, 1991, we placed implantable hepatic arterial infusion devices in 180 patients. The records of these patients were reviewed to determine (1) the incidence and surgical management of variant hepatic arterial anatomy and (2) the complications associated with surgical placement of these devices.
      Results. Variant hepatic arterial anatomy requiring ligation of the variant vessel or nonstandard cannulation was seen in 66 patients (36.7%). Treatment response rates and duration of treatment were no different for these 66 patients than for the 114 patients with standard hepatic arterial anatomy (p = 0.94). There were no operative deaths in this series. Operative or early postoperative (within 30 days) complications occurred in 10 patients (5.5%). However, late complications or device-related malfunctions developed in 52 patients (28.8%).
      Conclusions. An understanding of regional arterial anatomy is required to surgically place a catheter to achieve bilobar hepatic arterial perfusion and avoid gastroduodenal misperfusion of drug. Placement of hepatic arterial infusion devices has a low rate of early morbidity, but surgeons should be aware of late complications that may develop in patients undergoing hepatic arterial chemotherapy infusion through an implantable device.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Blackshear PJ
        • Dorman FD
        • Blackshear Jr, PL
        • et al.
        The design and initial testing of an implantable infusion pump.
        Surg Gynecol Obstet. 1972; 134: 51-56
        • Kemeny N
        • Daly J
        • Oderman P
        • et al.
        Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.
        J Clin Oncol. 1984; 2: 595-600
        • Kemeny N
        • Daly J
        • Reichman B
        • et al.
        Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: a randomized trial.
        Ann Intern Med. 1987; 107: 459-465
        • Stagg RJ
        • Venook AP
        • Chase JL
        • et al.
        Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
        J Natl Cancer Inst. 1991; 83: 423-428
        • Reed ML
        • Vaitkevicius VK
        • Al-Sarraf M
        • et al.
        The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results in 124 patients in a prospective protocol.
        Cancer. 1981; 47: 402-409
        • Clouse ME
        • Ahmed R
        • Ryan RB
        • et al.
        Complications of long term transbrachial hepatic arterial infusion chemotherapy.
        AJR. 1977; 129: 799-803
        • Bible KC
        • Hatfield AK
        • Lansford CL
        • Kammer BA
        Gastric ulceration as a complication of hepatic artery infusion chemotherapy.
        South Med J. 1986; 79: 755-757
        • Shike M
        • Gillin JS
        • Kemeny N
        • et al.
        Severe gastroduodenal ulcerations complicating hepatic artery infusion chemotherapy for metastatic colon cancer.
        Am J Gastroenterol. 1986; 81: 176-179
        • Hohn DC
        • Stagg RJ
        • Price DC
        • et al.
        Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2 deoxyuridine.
        J Clin Oncol. 1985; 3: 1257-1260
        • Michels NA
        Blood supply and anatomy of the upper abdominal organs with a descriptive atlas. JB Lippincott, Philadelphia1955: 152-154
        • Michels NA
        Blood supply and anatomy of the upper abdominal organs with a descriptive atlas. JB Lippincott, Philadelphia1955: 256-259
        • Michels NA
        2nd ed. Blood supply and anatomy of the upper abdominal organs with a descriptive atlas. JB Lippincott, Philadelphia1955: 374-375
        • Michels NA
        Newer anatomy of the liver and its variant blood supply and collateral circulation.
        Am J Surg. 1966; 112: 337-347
        • Kemeny MM
        • Hogan JM
        • Goldberg DA
        • et al.
        Continuous hepatic artery infusion with an implantable pump: problems with hepatic artery anomalies.
        Surgery. 1986; 99: 501-504
        • Albano WA
        • Durr M
        • Gutierrez AR
        • et al.
        Hepatic artery infusion: surgical approach.
        Cancer Drug Del. 1984; 1: 213-226
        • Rayner AA
        • Kerlan RK
        • Stagg RJ
        • et al.
        Total hepatic arterial perfusion after occlusion of variant lobar vessels: implications for hepatic arterial chemotherapy.
        Surgery. 1986; 99: 708-714
        • Chuang VP
        • Wallace S
        Hepatic arterial redistribution for intraarterial infusion of hepatic neoplasms.
        Radiology. 1980; 135: 295-299